findmyKOL

Yogenthiran Saunthararajah

Basic profile

Cleveland Clinic

ORCIDNone on fileNPI↗
✓ Full record
RegionCleveland, OH · MidwestSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL type: RegionalLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Yogenthiran Saunthararajah is an Oncology physician affiliated with Cleveland Clinic. OpenAlex indexes 73 publications with 267 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
73publications

Distinct works indexed by OpenAlex.

267citations

Total citations across indexed works.

7h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

9500 Euclid Ave
Cleveland, OH 441950001

Telephone

216-444-2200

Registry record last updated 2 Nov 2011.

View the NPPES registry record

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    48.5%
    Kinase inhibitor22.4%
    Jakafi81%Rydapt19%
    Part D<11 patients
    Calcineurin inhibitor7.8%
    Tacrolimus54%Cyclosporine Modified46%
    Part D<11 patients

    + 4 more classes in this area

  • Genitourinary & hormones

    16.2%
    Androgen16.2%
    Danazol100%
    Part D≥12 patients
  • Blood & clotting

    13.4%
    Thrombopoietin Receptor Agonist9.8%
    Promacta100%
    Part D<11 patients
    Factor Xa inhibitor3.6%
    Eliquis100%
    Part D<11 patients
Where care is delivered (Part B)86.8% facility · 13.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”